0001123292-17-001438.txt : 20170921 0001123292-17-001438.hdr.sgml : 20170921 20170921155343 ACCESSION NUMBER: 0001123292-17-001438 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170621 FILED AS OF DATE: 20170921 DATE AS OF CHANGE: 20170921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Keefer Jason CENTRAL INDEX KEY: 0001717590 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32966 FILM NUMBER: 171095812 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001360886 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 710881115 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 443-545-1819 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2017-06-21 0 0001360886 OSIRIS THERAPEUTICS, INC. OSIR 0001717590 Keefer Jason 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 0 1 0 0 Interim President & CEO Incentive Stock Option (right to buy) 16.24 2015-02-17 2025-02-17 Common Stock 15000 D Incentive Stock Option (right to buy) 19.20 2016-09-21 2026-09-21 Common Stock 1000 D 3,750 shares underlying this option shall vest on each of February 17, 2015, February 17, 2016, February 17, 2017 and February 17, 2018, subject to Reporting Person's continued service through the applicable vesting date. 250 shares underlying this option shall vest on each of September 21, 2016, September 21, 2017, September 21, 2018 and September 21, 2019, subject to Reporting Person's continued service through the applicable vesting date. /s/ Jason Keefer 2017-09-21